Kukje Pharma Revenue

Kukje Pharma had revenue of 45.63B KRW in the quarter ending September 30, 2025, with 15.09% growth. This brings the company's revenue in the last twelve months to 173.80B, up 15.77% year-over-year. In the year 2024, Kukje Pharma had annual revenue of 156.46B with 15.58% growth.

Revenue (ttm)

173.80B

Revenue Growth

+15.77%

P/S Ratio

0.51

Revenue / Employee

700.79M

Employees

248

Market Cap

88.88B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	156.46B	21.09B	15.58%
Dec 31, 2023	135.37B	8.79B	6.94%
Dec 31, 2022	126.58B	6.84B	5.71%
Dec 31, 2021	119.75B	-10.65B	-8.17%
Dec 31, 2020	130.39B	19.27B	17.34%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	5,504.84B
Celltrion	3,895.99B
ALTEOGEN	202.18B
ABL Bio	88.44B
SK Biopharmaceuticals	675.41B
Yuhan	2,136.67B
LigaChem Biosciences	159.27B
Peptron	6.19B

Revenue Rankings